Januvia

Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs
Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs
Endpoints
Merck
Viatris
patents
diabetes
Januvia
Janumet
Flag link:
Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
Endpoints
Merck
nitrosamine
diabetes
Januvia
Janumet
drug manufacturing
Flag link:
Merck celebrates another win in Januvia patent battle against Viatris
Merck celebrates another win in Januvia patent battle against Viatris
Endpoints
Merck
Januvia
patents
legal
diabetes
Viatris
Flag link:
Merck pulls a patent win for diabetes franchise in West Virginia federal court
Merck pulls a patent win for diabetes franchise in West Virginia federal court
Endpoints
Merck
Januvia
Janumet
generics
legal
Viatris
Flag link:
FDA says found possible carcinogen in certain samples of Merck's Januvia
FDA says found possible carcinogen in certain samples of Merck's Januvia
Yahoo/Reuters
Merck
Januvia
FDA
diabetes
carcinogens
Flag link:
The top 15 blockbuster patent expirations coming this decade
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Flag link:
Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?
Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?
Fierce Biotech
COVID-19
pandemic
Merck
Januvia
diabetes
Boehringer Ingelheim
Eli Lilly
Tradjenta
Flag link:
The top drugs facing cuts under Pelosi's pricing plan
The top drugs facing cuts under Pelosi's pricing plan
Biopharma Dive
drug pricing
Nancy Pelosi
regulatory
Revlimid
Keytruda
Opdivo
Januvia
insulin
Medicare
Flag link:
Novo Nordisk trumpets more Januvia-topping data for oral semaglutide
Novo Nordisk trumpets more Januvia-topping data for oral semaglutide
Fierce Pharma
Novo Nordisk
semaglutide
Merck
Januvia
HbA1C
Flag link:
Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
Fierce Pharma
Novo Nordisk
diabetes
semaglutide
Victoza
Merck
Januvia
Flag link:
Januvia and Janumet: An Update on Merck’s Diabetes Franchise after 2Q17
Januvia and Janumet: An Update on Merck’s Diabetes Franchise after 2Q17
Market Realist
Merck
diabetes
Januvia
Janumet
Flag link:
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
diabetes
Merck
Pfizer
SGLT2 inhibitor
Januvia
Invokana
Farxiga
Jardiance
Eli Lilly
Boehringer Ingelheim
AstraZeneca
JNJ
Flag link:
Top 10 diabetes drugs by 2016 sales
Top 10 diabetes drugs by 2016 sales
Fierce Pharma
diabetes
Sanofi
Novo Nordisk
Eli Lilly
Merck
Lantus
Januvia
Victoza
Levemir
Humalog
Novolog
Invokana
Flag link:
Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value
Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value
Forbes
Merck
diabetes
Januvia
Janumet
Eli Lilly
Flag link:
FDA nixes Merck’s shot at getting Januvia cardio safety data onto the label
FDA nixes Merck’s shot at getting Januvia cardio safety data onto the label
Endpoints
Merck
FDA
Januvia
Flag link:
Januvia, Vaccines May Drive Merck’s Revenue Growth in 2017
Januvia, Vaccines May Drive Merck’s Revenue Growth in 2017
Market Realist
Merck
Januvia
diabetes
vaccines
Flag link:
Merck Continues to Dominate with Its Januvia Franchise
Merck Continues to Dominate with Its Januvia Franchise
Market Realist
Merck
Januvia
diabetes
Flag link:
Merck inks pay-for-performance deal to boost diabetes drugs
Merck inks pay-for-performance deal to boost diabetes drugs
BioPharma Dive
Merck
pay-for-performance
diabetes
Janumet
Januvia
Aetna
Flag link:
What Are Merck’s Key Diabetes Products?
What Are Merck’s Key Diabetes Products?
Market Realist
Merck
diabetes
Januvia
Janumet
Flag link:
Merck Results Underscore Need To Go Big Or Go Home In Diabetes Market
Merck Results Underscore Need To Go Big Or Go Home In Diabetes Market
Forbes
Merck
diabetes
Sanofi
Januvia
Lantus
Flag link:

Pages